Lilly Diabetes Joins the American Diabetes Association as a National Sponsor of the 2013 Tour de Cure® Cycling Event

 Lilly Diabetes Joins the American Diabetes Association as a National Sponsor
                   of the 2013 Tour de Cure® Cycling Event

More than 60,000 cyclists expected to participate in the signature fundraising

News Highlights:

- Lilly Diabetes joins American Diabetes Association as a national sponsor of
its Tour de Cure cycling event to help #StopDiabetes

- Lilly Diabetes will support local & national riders, part of Tour de Cure's
60,000+ participants to help people with #diabetes

- Lilly Foundation will match employee donations of $25 or more to support
Tour de Cure fundraising efforts for #diabetes

PR Newswire

INDIANAPOLIS, Nov. 27, 2012

INDIANAPOLIS, Nov. 27, 2012 /PRNewswire/ -- Today Lilly Diabetes announced it
has joined the American Diabetes Association (Association) as a national
sponsor of the 2013 Tour de Cure, the Association's annual nationwide cycling
event that attracts more than 60,000 riders across 44 states.

Lilly Diabetes has been an active supporter of the Association's efforts to
Stop Diabetes® through support of key organizational initiatives including
Living with Type 2 Diabetes, Everyday Wisdom™ kits, Safe at School® and
diabetes camps. For more than 10 years Lilly Diabetes has been one of the
largest supporters of diabetes summer camps in the U.S.

"Lilly Diabetes supports the Tour de Cure because at its heart, this event is
a celebration of health, hope and community," said Enrique Conterno,
president, Lilly Diabetes."It also helps connect our employees with one
another, and importantly, to connect them with the diabetes community we are
dedicated to serving."

The Tour de Cure is one of the Association's signature fundraising events in
which the organization's Stop Diabetes movement comes to life, encouraging
participants to: Share, Act, Learn and Give. The Tour asks riders and donors
to start a chain reaction by supporting its year-long series of cycling events
across the country. Riders with type 1 or type 2 diabetes, as well as those
who support them, can participate in courses of varying distances regardless
of skill level. In 2013, Lilly Diabetes employees will participate as local
and national team riders and will host local events and company-wide
fundraising activities. The Lilly Foundation will match individual employee
donations of $25 or more. In 2011, more than $18 million was raised to support
the mission of the American Diabetes Association: to prevent and cure diabetes
and to improve the lives of all people affected by diabetes.

"Lilly Diabetes has truly been passionate in supporting the American Diabetes
Association's mission and becoming part of our movement to Stop Diabetes,"
said Larry Hausner, CEO, American Diabetes Association. "We are excited to be
working together again to help raise critical funds for diabetes through our
Tour de Cure events nationwide."

Diabetes affects nearly 26 million children and adults in the United States –
8.3 percent of the U.S. population. It is estimated that an additional 79
million have prediabetes, putting them at risk for developing type 2 diabetes.
Diabetes can lead to blindness, heart disease, stroke, kidney failure and
amputations. Some common symptoms/signs of diabetes are extreme thirst,
frequent urination, blurry vision, and tingling in the feet.

To register to ride, visit

About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced
the world's first commercial insulin. Today we work to meet the diverse needs
of people with diabetes through research and collaboration, a broad and
growing product portfolio and a continued commitment to providing real
solutions–from medicines to support programs and more–to make lives better.
For more information, visit

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of pharmaceutical products by applying the latest research from its
own worldwide laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides
answers—through medicines and information—for some of the world's most urgent
medical needs. Information about Lilly is available at

HI80116 11/2012 PRINTED IN USA ©Lilly USA, LLC 2012. All rights reserved.


(Logo: )

(Logo: )

SOURCE Eli Lilly and Company

Contact: Julie Williams, Communications Manager, Lilly Diabetes,
+1-317-627-4056 (mobile/text),; or Brittany Korb,
MSLGROUP, +1-312-861-5214 (office),
Press spacebar to pause and continue. Press esc to stop.